Hyphen BioMed

Name

Hyphen BioMed

Legal name

HYPHEN BioMed SASU

Website

https://hyphen-biomed.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (33911)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• In vitro diagnostics
• Hemostasis reagents
• Coagulation testing
• Thrombosis diagnostics
• Clinical diagnostic reagents

Headquarters

HQ city

Neuville-sur-oise

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. In Vitro Diagnostic Reagent Sales: Sale of diagnostic reagents for blood coagulation, thrombosis, and auto-immunity testing. Products are available in ready-to-use or freeze-dried formats for automated or manual laboratory applications.
2. Instrument and Accessory Sales: Sale of instruments and instrument-related accessories and consumables alongside reagents, as described in the terms and conditions of sale.
3. Research Product Sales (RUO): Sale of Research Use Only (RUO) purified proteins, enzymes, recombinant proteins, chromogenic substrates, and ELISA kits for research applications.
4. Calibrators and Controls: Sale of multi-calibrators, specific calibrators, and quality control plasmas for laboratory quality assurance.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

HYPHEN BioMed manufactures and sells in vitro diagnostic reagents for hemostasis, thrombosis, fibrinolysis, and auto-immunity disorders, offering more than 500 products across clotting, chromogenic, and ELISA methodologies. Products are available in ready-to-use or freeze-dried formats for automated or manual laboratory applications, sold globally through specialized distributors to hospital laboratories, medical researchers, and pharmaceutical companies. The portfolio is CE-IVD marked, FDA 510(k) cleared, and produced under ISO 13485:2016 and MDSAP quality systems.

Product overview

Hyphen BioMed is a Sysmex Group Company specializing in in vitro diagnostic medical devices for hemostasis science. The company offers over 500 products across multiple specialized product lines including BIOPHEN (chromogenic/clotting assays), ZYMUTEST (ELISA kits), ZYMUPHEN (immunoassays), HEMOCLOT (clotting assays), CEPHEN (lupus anticoagulant), FIBRIPHEN, PT-phen, and LIAPHEN. Product categories span Global & Routine Tests (PT, aPTT, Fibrinogen), Primary Hemostasis (platelet aggregation), Bleeding Disorders (hemophilia, vWD), Thrombophilia (AT, PC, PS, LA), Monitoring Anticoagulant (Anti-Xa, Anti-IIa), Fibrinolysis, Calibrators/Controls, Research-use-only products, and Auxiliary Reagents. The portfolio includes both CE-IVD and 510(k) cleared diagnostic reagents, with IVDR registration in process, available in ready-to-use or freeze-dried formats for automated or manual laboratory applications.

Differentiator

Problem solved

Functional benefit

Brands

• BIOPHEN: Product line for chromogenic and clotting assays for coagulation factors, heparin, and anticoagulant monitoring.
• ZYMUTEST
• ZYMUPHEN
• HEMOCLOT
• CEPHEN
• FIBRIPHEN
• PT-phen
• LIAPHEN
• AGGREGOMETRY

Products and services

• BIOPHEN Product Line Proprietary line of chromogenic and clotting assays for coagulation factor measurement, heparin and direct oral anticoagulant monitoring (Anti-Xa, Anti-IIa), and reference plasmas, including BIOPHEN NormalPlasma control. Available in ready-to-use or freeze-dried formats for automated or manual laboratory applications.

Quantifiable outcome

• 96/100 gender equality index score in 2025, demonstrating strong workplace practices.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• Sysmex CorporationcoreStrategic or Co-development PartnerSysmex Corporation is the parent company of Hyphen BioMed, as stated in the product catalog: 'Manufactured by HYPHEN BioMed a Sysmex Group Company.' This affiliation provides Hyphen BioMed with integration into the Sysmex group's global diagnostics ecosystem, including shared distribution channels (Sysmex Europe SE) and technological synergies in hematology and hemostasis diagnostics.
• Sysmex Europe SEcoreChannel Partner/ Reseller/ DistributorSysmex Europe SE, headquartered in Hamburg, Germany, serves as a key distributor for Hyphen BioMed products across multiple countries including Angola, Kuwait, Egypt, and other territories. The distributor contact details (Deelböge 19 D, 22297 Hamburg, Germany; +49 40 527 260; [email protected]; www.sysmex-europe.com) are listed in Hyphen BioMed's partner directory.

Scale indicators6 records

Recent moves1 record

Direct peers

• Werfen (Instrumentation Laboratory): Specialized hemostasis and acute care diagnostics player with the ACL TOP analyzer family and hemostasis reagent portfolio (including HemosIL). Directly comparable to Hyphen BioMed in hemostasis product focus, clinical customer base, and proprietary assay technology.
• Helena Biosciences: Specialty hemostasis and thrombophilia diagnostics company offering reagent kits and analyzers. Comparable to Hyphen BioMed in therapeutic focus (thrombosis, lupus anticoagulant, factor deficiencies) and customer base of hospital hemostasis labs.
• Diagnostica Stago: France-based global leader in hemostasis and thrombosis diagnostics, manufacturing both coagulation analyzers and a comprehensive IVD reagent catalog. Stago is Hyphen BioMed's most direct competitor in the hemostasis specialty, especially across CE-IVD markets and hospital labs in Europe.
• Randox Laboratories: UK-based IVD manufacturer offering a broad reagent catalog including hemostasis and coagulation assays. Randox competes with Hyphen BioMed in specialty IVD reagents for clinical labs, with comparable product breadth across routine and specialty coagulation markers.

Broad incumbents

• Siemens Healthineers: Global diagnostics giant offering the INNOVANCE hemostasis reagent line alongside its Atellica coagulation analyzers. While serving a much broader diagnostics portfolio, Siemens competes head-to-head with Hyphen BioMed for hospital lab hemostasis reagent contracts worldwide.
• Roche Diagnostics: One of the largest global IVD players with cobas coagulation analyzers and a broad hemostasis reagent catalog. Roche competes with Hyphen BioMed across routine and specialty coagulation testing, leveraging scale and integrated instrument-reagent systems.
• Bio-Rad Laboratories: Clinical diagnostics manufacturer with quality controls and hemostasis reagents used by hospital and reference labs. While Bio-Rad's diagnostics focus is broader (controls, immunology, blood typing), it overlaps with Hyphen BioMed in the lab consumables and hemostasis reagents space.
• Abbott Diagnostics: Global diagnostics major offering hemostasis reagents and analyzers within a broad IVD and core lab portfolio. Competes with Hyphen BioMed in hospital laboratory hemostasis testing, though hemostasis is a smaller slice of Abbott's overall diagnostics business.

Others

• Sysmex Corporation: Parent company of Hyphen BioMed and a global leader in hematology and coagulation diagnostics with the CS-series analyzers. While Sysmex is the corporate parent, it is also a market participant whose hemostasis analyzers and reagents compete in the same labs Hyphen BioMed serves via its own catalog.

Emerging players

• HORIBA Medical: In vitro diagnostics subsidiary of HORIBA, offering hematology and clinical chemistry analyzers with associated reagent menus. Partially overlaps with Hyphen BioMed in hospital lab workflows, particularly where labs combine hematology and hemostasis testing.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hyphen-biomed

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hyphen BioMed